Valuation : Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 925K 873K 795K 1.48M 102M 1.5M 10.38M 4M 52.11M 4.03M 3.94M 166M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 712K 672K 612K 1.14M 78.89M 1.16M 7.99M 3.08M 40.12M 3.1M 3.04M 128M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day+0.14%
1 week-0.14%
Current month-0.14%
1 month-0.14%
6 months+40.00%
Current year+133.33%
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 2019-06-25
Director TitleAgeSince
Director/Board Member 64 2002-12-31
Director/Board Member 84 2004-12-31
Director/Board Member - 2018-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-0.14%+600.00%-97.27% 26.4K
+0.16%-0.88%-1.20%+47.32% 3,651B
-2.16%-2.12%+2.16%+996.23% 407B
+0.12%-7.08%-21.23%+19.73% 78.38B
-1.58%+5.97%+57.85%+127.03% 80.89B
+1.00%-4.52%-34.28%-13.50% 75.36B
-0.94%-4.54%-44.11%+181.54% 66.58B
+1.03%-3.68%-1.53%-13.08% 44.99B
+2.76%+0.38%-12.47%+51.96% 39.48B
+1.73%+1.93%+116.01%+252.98% 34.89B
Average +0.41%-1.67%+66.12%+155.30% 447.87B
Weighted average by Cap. -0.33%-1.05%-0.56%+136.60%

Financials

2015 2016
Net sales 4.22M 3.64M 3.43M 3.12M 5.84M 403M 5.9M 40.81M 15.71M 205M 15.85M 15.51M 652M 3.04M 2.62M 2.48M 2.25M 4.21M 291M 4.26M 29.43M 11.33M 148M 11.43M 11.18M 470M
Net income 151K 130K 123K 112K 209K 14.41M 211K 1.46M 562K 7.33M 567K 555K 23.31M -344K -296K -280K -255K -476K -32.83M -481K -3.32M -1.28M -16.7M -1.29M -1.26M -53.1M
Net Debt -340K -293K -276K -252K -470K -32.45M -475K -3.29M -1.27M -16.5M -1.28M -1.25M -52.48M -247K -213K -201K -183K -342K -23.57M -345K -2.39M -919K -11.99M -927K -907K -38.12M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!